EGTX.ST 2026 investigator abstract safety and replication of ReTRIACt estimates = 6
Catalyst run-ups2026-09-08 04:05
ETA2026 abstract accessibleSep8, first posting day unverified. Same15randomized trial and estimates, not new independent trial: PE1p.0341/PE2p.182; sixSAEsinfour subjects, none judged treatment-related by investigators; one aspiration-pneumonia/respiratory-failure death. Includes sponsor/consultant coauthors. Do not infer drug causality from death or zero risk from investigator attribution.
https://www.endocrine-abstracts.org/ea/0119/ea0119op-03-05
EGTX.ST 2024 survival abstract selection and confounding limits = 228
Catalyst run-ups2026-09-08 04:05
Investigator-origin ETA2024 abstract collectedSep8; 484screened/228included,111treated/117untreated; excluded152bornbefore2004,68limiteddata,36unknownmutationfunction. Medianfollowup4.8y; deaths5vs27; adjustedHR.28 CI.09–.91. Westernresidency78%treatedvs57%untreated. Authors explicitly still addressing confounding/immortal-time bias. This vintage is not sponsor's later>600dataset; final dataset/analysis unavailable in bounded search. Same patients recur across sponsor citations; not independent replications.
https://www.endocrine-abstracts.org/ea/0101/ea0101op-03-04
BTC/USD SideSwap service proof fields versus liquidity and intermediary peg-in
Crypto majors2026-09-08 04:05
Primary documentation readSep8 04:03UTC. API server_status gives minimums/fees; subscribed_value gives hotwallet liquidity; peg_status includes payout_txid/status per order. FAQ says customer BTC goes to SideSwap taproot wallet and L-BTC credited from its hotwallet, with federation batching behind scenes. API examples explicitly testnet/regtest, not live evidence. Therefore available balance or successful peg-in does not itself establish functioning federation pegout. Live completed payout must be tied to current chain and specific order; no user order identifiers supplied, no test transfers authorized/attempted.
https://sideswap.io/docs/ ; https://sideswap.io/faq/peg-in-out/
BTC/USD Direct operator restart-preparation update supersedes inaccessible-source gap = 1788829247
Crypto majors2026-09-08 04:05
Fetched direct X profile and specific post HTTP200 Sep8~04:05UTC via requests; web browser fetch403 differs by access path. Embedded author Blockstream, post2097127976672342487,created_at_ms1788829247000=Sep8 01:00:47UTC. Says updated software deployed, federation members preparing coordinated restart, ongoing hardening. Confirms origin of Reddit wording, one issuer source not two independent sources. Update was already public before04UTC; not a fresh tradable surprise. Preparation is not completed restart or demonstrated payout; controller of reserve keys and current liabilities remain unverified.
https://x.com/Blockstream/status/2097127976672342487
BTC/USD Signed affirmative reply verifies under published security key = 1
Crypto majors2026-09-08 04:05
Raw OP_RETURN mathematical signature TRUE under fingerprint1176542DA98E71E133722EF74AC8CC886844A2D6 viaPGpy. Sep7 03:30:05UTC block965875. Plaintext affirmative reply; dialogue context suggests approval of recipient-proposed return address, but message itself does not name address or prove current reserve signing control. Same certificate audit limitations as patch observation; no claim about private encrypted messages.
https://blockstream.info/api/tx/8a444eed65c4584f138e08ee138f61490ef73e84f71e14dac3ca66c230cf7e97 ; https://blockstream.com/pgp.txt
BTC/USD Independent mathematical verification of on-chain patch statement = 1
Crypto majors2026-09-08 04:05
Sep8 ~04:05UTC fetched raw tx OP_RETURN and issuer HTTPS public key; local PGpy0.6 signature check TRUE, fingerprint1176542DA98E71E133722EF74AC8CC886844A2D6. Message says bridge nodes patched and safe to return funds. Bitcoin confirmation Sep7 09:41:26UTC height965912, not first-seen publication time. Normalized blank line before public-key END armor only; message bytes preserved. PGpy warns revocation/self-signature/disabled flag checks unimplemented: mathematical match and current-domain key publication, not complete certificate audit or proof software is safe. Gist used solely as locator, self-labels machine-written; no dependence on its verification assertion. No exploit code executed.
https://blockstream.com/pgp.txt ; https://blockstream.info/api/tx/3c101c8e053a6cbc7c4455e4fec017c8f2962ed86dee70e72fb8bafbb1d7bde9
Issuer Sep4 2026 snapshot retrievedSep8:close98.28,NAV98.07,nonFV NAV97.62,premium.22%,30daymedianbidask.01%,assets23.506bnUSD,shares239.7m,holdings167;expense.49%,P/E19.26,P/B2.08;industrials24.08%,financials19.63%,IT18.06%. Foreignprice/FXvaluation clocks differ, and fairvaluation may explain benchmark divergence. Issuer markets fund; figures are current descriptive exposure, not point-in-time historical valuation signals. Atcap212.7475fits2shares. NarrowETFspread does not establish reboundalpha.
https://www.ishares.com/us/products/239665/ishares-msci-japan-etf
December2012 author draft. Live1998-2011 cost sample19developed markets, monthly priorreturn longshortSTR and1day skip; optimized1980-2011 tradable-universe test starting100mUSD stillfails, annualcost6.17%vs10.82%unoptimized. Other samples show positive finite STR capacity, so this is not proof a245.69USD ETF book cannot work. Different universe/horizon/cost construction reconciles apparent disagreement with2011deGroot. Primary institutional research, one-manager cost sample.
https://pages.stern.nyu.edu/~afrazzin/pdf/Trading%20Cost%20of%20Asset%20Pricing%20Anomalies%20-%20Frazzini,%20Israel%20and%20Moskowitz.pdf
QREV90804 published reversal construction and cost counterevidence = 50
Quant replication2026-09-08 04:04
July2011 accepted author manuscript, US1990-2009/Europe1995-2009. Daily quintiles use lagged5day returns, skip1day, equalweight longlosers/shortwinners. Large-cap and buffer-to-middle-rank portfolios report up to30-50bp/week net US,20bp Europe; Nomura cost estimates differ from older Keim-Madhavan extrapolations. Institution-affiliated authors, original research not independent live ETF execution. This is counterevidence to categorical reversal rejection, not expected ETF return.
https://repub.eur.nl/pub/25718/AnotherLook_2011.pdf
BTC/USD Liquid explorer disagreement and stale tips = 897
Crypto majors2026-09-08 04:04
Read04:03:49–50UTC Sep8. Blockstream tip4051232 timestamp1788756550 age83679s,1tx; liquid.network4050335 timestamp1788702730 age137501s,5tx. Difference897blocks. Indexer staleness/chain disagreement confounds network-wide liveness inference; two domains not established independent backends. Block production alone would still not prove successful pegout.
https://blockstream.info/liquid/api/blocks ; https://liquid.network/api/blocks
BTC/USD Fully paginated reserve has no later confirmed controlled spend = 3597.47197696
Crypto majors2026-09-08 04:04
Primary indexer04:03:48UTC,580 unique confirmedtx through empty terminalpage25requests;209 controlled spends; latest965804 precedes principal return965950. Mempool count0. No later confirmed reserve spend in this address history; this is not complete federation wallet coverage or proof of unavailable withdrawals. Read-only; no ownership keys tested.
https://blockstream.info/api/address/bc1qdlld6antmv4xug242ed83q7k4rqw50cwfns38szx4qu2f4jwaxxsuhwxxr/txs/chain
EMA page updatedMar11 2025, collectedSep8: EU authorizationFeb12 2025 for peripheral thyrotoxicosis in MCT8deficiency from birth. Uncontrolled46patient mainstudy meanT3 4.97to1.82nmol/L at12months; supportive small clinical improvements. EU risk-benefit finding supports that indication, not US decision or proven neurological recovery; one independent regulatory origin distinct from sponsor.
https://www.ema.europa.eu/en/medicines/human/EPAR/emcitate
EGTX.ST Triac II neurodevelopment endpoint failure = 0
Catalyst run-ups2026-09-08 04:04
Jun19 2024 18:50CEST issuer-origin release, collectedSep8: youngpatients<30months did not meet GMFM88/BSIDIII co-primary superiority versus historical controls; T3 reduction remained. Sponsor viewed peripheral-thyrotoxicosis approval case unaffected; do not equate biochemical success with neurological efficacy.
https://view.news.eu.nasdaq.com/view?id=b6932fc249aad17eed868793c5ebb91ad&lang=en&src=micro
EGTX.ST ReTRIACt endpoint hierarchy and SAP revision = 0.034
Catalyst run-ups2026-09-08 04:04
Nov14 2025 sponsor release collectedSep8: 15 randomized stabilized males>=4y; withdrawal30days. AfterOct2025 preNDA discussion SAP revised, added PE1 T3 rate before existing rescue PE2, alpha recycling. PE1 ratio1.494 CI1.035–2.155,p.034; placebo8/tiratricol7. Observedrescues4/8vs0/6,p.070; SAPimputed discontinuation gives4/8vs1/7,p.182 PE2. Sponsor says complementary rather than pivotal after FDA discussion; regulator meeting minutes not obtained. Endpoint modification not alone proof of invalidity; no approval probability inferred.
https://www.egetis.com/sv/mfn_news/egetis-meddelar-positiva-resultat-fran-retriact-studien-med-emcitate-tiratricol-vid-mct8-brist/
CollectedSep8 04UTC: pipeline page says NDA completedSep29 2026 while anticipating decisionSep2026, internally future-dated. Jan29 2026 dated completion https://www.egetis.com/mfn_news/egetis-completes-the-u-s-rolling-nda-submission-for-emcitate-tiratricol-for-treatment-of-mct8-deficiency/ and Mar27 acceptance https://www.egetis.com/mfn_news/egetis-announces-fda-acceptance-and-priority-review-of-nda-for-emcitate-tiratricol-for-mct8-deficiency/ support Jan submission and Sep28 target. Treat undated text as chronology error, not amendment; all sponsor sources one origin.
https://www.egetis.com/pipeline/
EGTX.ST Q2 primary financing and conditional voucher economics = 378.4
Catalyst run-ups2026-09-08 04:04
Issuer Aug21, collectedSep8 04UTC, periodQ2/H1 2026; sponsor-origin unaudited. Cash378.4MSEK; Q2 CFO-93.9,investing-2.7,financing326.8; raise350 less18.9fees; loans/leases repayment8.7. Ordinary shares464947224 versus395162672Jan1; treasury C25881381 distinct; options/warrants42311653. Revenue17.4MSEK Q2; retains50% NET PRV proceeds, conditional on approval/issuance/sale. Sep28 PDUFA retained after mid/latecycle meetings; no adcom planned per sponsor, not FDA approval. EAP~60patients/17hospitals not paid US sales.
https://attachment.news.eu.nasdaq.com/aa8bae6e3da62b95404c23eb6ec2cc25a
BDRBF September7 political sales-ban claim attribution
Supply chain2026-09-08 04:04
ClaimSept7 13:39 archive displayedtimezoneunverified, readSep8. Archive https://www.trumpstruth.org/?per_page=100 links thisexactoriginal and reproduces demand tohaltBombardierUSsalesunlessbuiltUS,claimover50%USrevenue andCanadaGulfstreamblocked. Original page returnednoextractabletext. Statementauthenticatedonlythrougharchive/link atthisstage; no signed instrument orscope/effective dateverified; revenuepercentage andCanadianban remain speakerclaims. Mediarepeats sameorigin,notcorroboration.
https://truthsocial.com/@realDonaldTrump/117230978314061095
July9 aircraft proclamation scope = 180
Supply chain2026-09-08 04:04
Government primary July9 2026, readSep8. Operative clauses direct Commerce/USTR negotiations and updatewithin180days; paragraph9 recommends no immediate232tariffs. This text does not establish aSeptember7 Bombardierban. SearchWhiteHouse/CBP/FederalRegister found no specific implementingban in scopedqueries; absenceofretrieval is not proofnoneexists. Politicalnational-security framing, not neutral economicstudy.
https://www.whitehouse.gov/presidential-actions/2026/07/adjusting-imports-of-commercial-aircraft-jet-engines-and-aircraft-and-engine-parts-into-the-united-states/
BTC/USD Blockstream-branded account describes preparation for coordinated restart
Crypto majors2026-09-08 04:03
Read Sep8 04:03UTC, title Sep7 2026; Reddit displays Sep8 publication, exact timestamp pending. Posted by blockstreamHQ: updated software deployed, federation members preparing coordinated restart and further hardening. Account branding not independently authenticated through issuer-domain link yet. Claim is preparation, not completed restart or paid pegout. Not independent corroboration of reposted exchange/news summaries.
https://www.reddit.com/r/blockstream/comments/1waaan2/liquid_network_update_september_7_2026/